These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4988771)

  • 41. Disc sentitivity as a diagnostic aid in the identification of group D enterococci.
    Lee WS
    Am J Med Technol; 1972 Dec; 38(12):496-500. PubMed ID: 4490310
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of pH of medium and size of inoculum on activity of antibiotics against group D Streptococcus (Enterococcus).
    Toala P; Wilcox C; Finland M
    Appl Microbiol; 1970 Apr; 19(4):629-37. PubMed ID: 4986728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro susceptibility of enterococci strains isolated from urine samples to fosfomycin and other antibiotics.
    Butcu M; Akcay SS; Inan AS; Aksaray S; Engin DO; Calisici G
    J Infect Chemother; 2011 Aug; 17(4):575-8. PubMed ID: 21287226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparative examination of Enterococci obtained from drinking water, foodstuffs and urine (author's transl)].
    Rakarowa N; Paparkowa K
    Zentralbl Bakteriol Orig B; 1973 Oct; 158(2):194-8. PubMed ID: 4205128
    [No Abstract]   [Full Text] [Related]  

  • 45. The antibiotic sensitivity of 100 isolates of Escherichia coli, with special reference to the domiciliary treatment of urinary tract infections.
    Anderson K
    Med J Aust; 1970 Aug; 2(9):409-11. PubMed ID: 4924022
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparative in vitro activity of norfloxacin and seven other antimicrobial agents against clinical isolates from urinary tract infections.
    Esko E; Renkonen OV
    Scand J Infect Dis; 1985; 17(1):95-8. PubMed ID: 3158071
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Occurrence of enteropathogenic serotypes of Escherichia coli in urinary tract infections].
    Schmid E; Sonnabend W
    Pathol Microbiol (Basel); 1973; 39(5):348-57. PubMed ID: 4580715
    [No Abstract]   [Full Text] [Related]  

  • 48. Evaluation of Enterococcus faecalis clinical isolates with 'penicillin-resistant, ampicillin-susceptible' phenotype as reported by Vitek-2 Compact system.
    Tan YE; Ng LS; Tan TY
    Pathology; 2014 Oct; 46(6):544-50. PubMed ID: 25158809
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activity of modern penicillins and cephalosporins against enterococci.
    Haller I; Heinrich S
    Arzneimittelforschung; 1982; 32(7):756-9. PubMed ID: 6812597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Susceptibilities of enterococci to twelve antibiotics.
    Tofte RW; Solliday JA; Crossley KB
    Antimicrob Agents Chemother; 1984 Apr; 25(4):532-3. PubMed ID: 6428309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Susceptibility of enterococci. I. Inhibitory and bactericidal activity of several chemoantibiotics against Streptococcus faecalis and Streptococcus faecium.
    Fabbri A; Manno G; Tacchella A; Belli ML; Palmero C
    Chemioterapia; 1986 Oct; 5(5):302-8. PubMed ID: 3098440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Current status of determining bacteria and resistance in urinary tract infections].
    Ritzerfeld W; Fegeler W
    Urologe A; 1984 May; 23(3):130-3. PubMed ID: 6539985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multicenter evaluation of use of penicillin and ampicillin as surrogates for in vitro testing of susceptibility of enterococci to imipenem.
    Weinstein MP; Mirrett S; Kannangara S; Monahan J; Harrell LJ; Wilson AC; Reller LB
    J Clin Microbiol; 2004 Aug; 42(8):3747-51. PubMed ID: 15297525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urinary infection in general practice. Diagnosis and treatment.
    Dawborn JK; Page M; Schiavone DJ; Semmens K; Smyth JL
    Med J Aust; 1973 May; 1(18):885-90. PubMed ID: 4577313
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical experience with parenteral ampicillin preparation (Pentrex 'Banyu')].
    Kimura Y; Adachi K; Miyata K
    Jpn J Antibiot; 1972 Apr; 25(2):61-4. PubMed ID: 4627211
    [No Abstract]   [Full Text] [Related]  

  • 57. In-vitro activity of azlocillin and other beta-lactam antibiotics against enterococci.
    Grimm H
    J Antimicrob Chemother; 1983 May; 11 Suppl B():43-9. PubMed ID: 6413483
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The recent aspects of group D Streptococcus sensitivity to antibiotics.
    Turcu T; Mihalcu F; Cuciureanu G; Negurţ E; Stănescu C
    Arch Roum Pathol Exp Microbiol; 1981; 40(3):199-204. PubMed ID: 6800340
    [No Abstract]   [Full Text] [Related]  

  • 59. In vitro activity of ampicillin/sulbactam against enterococci determined by the time-kill method.
    D'Amato RF; Mathew A; Hochstein L; Cleri DJ; Johnson J
    Diagn Microbiol Infect Dis; 1989; 12(1):9-11. PubMed ID: 2496949
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimicrobial susceptibility pattern of Enterococcus species from urinary tract infections.
    Miskeen PA; Deodhar L
    J Assoc Physicians India; 2002 Mar; 50():378-81. PubMed ID: 11922226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.